Company Overview

Company name: Spot Therapeutics
Description: Provider of cannabis based products.
Year founded:
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Fredericton
State: New Brunswick
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Acquired/Merged
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was acquired by Canopy Growth (TSE: WEED) for CAD 2.25 million on August 28, 2017. Under the terms of the transaction, shareholders of Spot will receive up to CAD2,250,000 in total consideration, less adjustments for all liabilities of Spot as of the closing date and certain payments to be made by Spot between closing and the second tranche payment. At closing, and in satisfaction of the first tranche payment of CAD 1,000,000, Canopy issued 111,669 common shares to the shareholders of Spot. The second tranche payment will be satisfied by the issuance of additional common shares, subject to completion of certain licensing and operational milestones. Closing of the acquisition of the industrial building and property in Fredericton is anticipated to close in early September.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 1.79
Last known valuation date: 28-Aug-2017